Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Cellular Physiology

• Publication date

  2001-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcp.1087PMID 11319763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-alpha.

  2000cited by this paper
• Bcl-2 related proteins are dramatically induced at the early stage of differentiation in human liver cancer cells by a histone deacetylase inhibitor projecting an anti-apoptotic role during this period.

  2000cited by this paper
• Up-regulation of E-cadherin and β-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-α

  2000cited by this paper
• Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.

  2000cited by this paper
• Direct activation of TERT transcription by c-MYC

  1999cited by this paper
• Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy.

  1999cited by this paper
• Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype

  1999cited by this paper
• Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes.

  1999cited by this paper
• Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-α in human hepatoma cell lines

  1999influential reference
• Inhibition of telomerase limits the growth of human cancer cells

  1999cited by this paper
• Telomere Length Dynamics and Chromosomal Instability in Cells Derived from Telomerase Null Mice

  1999cited by this paper
• Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms

  1999cited by this paper
• Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells.

  1999cited by this paper
• Hepatocellular carcinoma

  1999cited by this paper
• Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.

  1998cited by this paper
• Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

  1998cited by this paper
• Pathology of early hepatocellular carcinoma: progression from early to advanced.

  1998cited by this paper
• Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment.

  1998cited by this paper
• Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines.

  1998cited by this paper
• Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase

  1998cited by this paper
• Loss of butyrate‐induced apoptosis in human hepatoma cell lines HCC‐M and HCC‐T having substantial Bcl‐2 expression

  1998cited by this paper
• Functionally interacting telomerase RNAs in the yeast telomerase complex.

  1997cited by this paper
• Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma

  1997cited by this paper
• Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.

  1997cited by this paper
• Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.

  1997cited by this paper
• Lack of cell cycle regulation of telomerase activity in human cells.

  1997cited by this paper
• Telomerase activity is detected in pancreatic cancer but not in benign tumors.

  1997cited by this paper
• Role of H‐ras gene in chronic liver damage in mice. By using transgenic mice carrying a human c‐H‐ras proto‐oncogene without mutations

  1997cited by this paper
• Cell cycle-dependent modulation of telomerase activity in tumor cells.

  1996cited by this paper
• Pathology of early hepatocellular carcinoma: progression from early to advanced.

  1996cited by this paper
• Telomerase regulation during entry into the cell cycle in normal human T cells.

  1996cited by this paper
• Regulation of telomerase activity in immortal cell lines

  1996cited by this paper
• Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.

  1996cited by this paper
• Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma

  1996cited by this paper
• Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells.

  1996cited by this paper
• Telomerase activity in germline and embryonic cells of Xenopus.

  1994cited by this paper
• Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells.

  1994cited by this paper
• Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer

  1994cited by this paper
• Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease.

  1994cited by this paper
• Reciprocal regulation of α-fetoprotein and albumin gene expression by butyrate in human hepatoma cells

  1994cited by this paper
• Hepatic tumors induced by carbon tetrachloride in transgenic mice carrying a human c‐H‐ras proto‐oncogene without mutations

  1994cited by this paper
• Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA.

  1994cited by this paper
• Hepatic tumors induced by carbon tetrachloride in transgenic mice carrying a human C-H-ras proto-oncogene without mutations

  1994cited by this paper
• Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells.

  1993cited by this paper
• Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53‐independent pathway: Implications for the possible role of dietary fibre in the prevention of large‐bowel cancer

  1993cited by this paper
• Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC‐M and HCC‐T

  1991cited by this paper
• Structure and function of telomeres

  1991cited by this paper
• Structure and variability of human chromosome ends

  1990cited by this paper
• Telomeres shorten during ageing of human fibroblasts

  1990cited by this paper
• A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis

  1989influential reference
• Structure and function of telomeres.

  1989cited by this paper
• Establishment of a human cell line (HCC‐T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection

  1989cited by this paper
• Establishment of a cell line (HCC‐M) from a human hepatocellular carcinoma

  1983influential reference
• The effect of sodium butyrate on histone modification.

  1978cited by this paper

• Rapid quantification of short-chain fatty acids by Fourier-transform infrared spectroscopy for microbiota quality assessment

  2025cites this paper
• Telomeres and Telomerase: Targets for Chemoprevention of Hepatocellular Carcinoma With Bioactive Food Compounds

  2025cites this paper
• Targeting 'histone mark': Advanced approaches in epigenetic regulation of telomere dynamics in cancer.

  2024cites this paper
• Role of microbiota short-chain fatty acid chains in the pathogenesis of autoimmune diseases.

  2023cites this paper
• Gut microbial metabolite butyrate improves anticancer therapy by regulating intracellular calcium homeostasis

  2023cites this paper
• Effect of Nanocurcumin in Combination with Methotrexate on Telomerase Activity, NF-kb Expression, and Proliferation Index of Bewo Choriocarcinoma Cells

  2023cites this paper
• Short-chain fatty acids in cancer pathogenesis

  2023cites this paper
• Modulation of Telomerase Gene in Liver Cancer by Natural Compounds

  2022cites this paper
• Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review

  2021cites this paper
• Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis.

  2021cites this paper
• The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea

  2020cites this paper
• From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs

  2019cites this paper
• Arylureas derived from colchicine: Enhancement of colchicine oncogene downregulation activity.

  2018cites this paper
• TELOMERASE REVERSE TRANSCRIPTASE IN ATHEROSCLEROSIS

  2017cites this paper
• Differential Regulation of Telomerase Reverse Transcriptase Promoter Activation and Protein Degradation by Histone Deacetylase Inhibition

  2016cites this paper
• The role of short-chain fatty acids in health and disease.

  2014cites this paper
• Alterations of epigenetics and microRNA in hepatocellular carcinoma

  2014cites this paper
• Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism.

  2013cites this paper
• Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication

  2013cites this paper
• Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis.

  2012cites this paper
• Histone deacetylase inhibition as an anticancer telomerase‐targeting strategy

  2011cites this paper
• Caractérisation de nouvelles fonctions biologiques et modifications post-traductionnelles du facteur d'épissage SC35 dans des modèles cellulaires de carcinomes pulmonaires

  2010cites this paper
• Differential roles of STIM1, STIM2 and Orai1 in the control of cell proliferation and SOCE amplitude in HEK293 cells.

  2010cites this paper
• Hepatocellular carcinoma in Keio affiliated hospitals--diagnosis, treatment, and prognosis of this disease.

  2009cites this paper
• Rôle des canaux calciques de la membrane plasmique dans la prolifération des cellules tumorales hépatiques

  2009cites this paper
• HDAC1 expression and effect of curcumin on proliferation of Raji cells

  2008cites this paper
• Targeting histone deacetylases for the treatment of disease

  2008cites this paper
• Effects of co-grafts mesenchymal stem cells and nerve growth factor suspension in the repair of spinal cord injury

  2008cites this paper
• Molecular Targeting in Hepatocellular Carcinoma

  2008cites this paper
• Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors

  2007cites this paper
• Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.

  2007cites this paper
• Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents.

  2007cites this paper
• Part 1 Synthesis of a potent histone deacetylase inhibitor; Part 2 Studies towards a stabilized helix-turn-helix peptide

  2007cites this paper
• Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad

  2006cites this paper
• Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor.

  2005cites this paper
• Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.

  2005cites this paper
• Clinical development of histone deacetylase inhibitors as anticancer agents.

  2005cites this paper
• Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylase.

  2005cites this paper
• Potent short-chain fatty acid-based histone deacetylase inhibitors as anti-tumor agents.

  2005cites this paper
• Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.

  2004cites this paper
• Acetylation of proteins as novel target for antitumor therapy: Review article

  2004cites this paper
• Analysis of the Cell Cycle and a Method Employing Synchronized Cells for Study of Protein Expression at Various Stages of the Cell Cycle

  2004cites this paper
• Telomerase, Telomerase Inhibition, and Cancer

  2003cites this paper
• Circadian telomerase activity and DNA synthesis for timing peptide administration.

  2003cites this paper
• Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.

  2003cites this paper
• In vitro induction of differentiation by ginsenoside Rh2 in SMMC-7721 hepatocarcinoma cell line.

  2003cites this paper
• Telomeres, Telomerase, and Telomerase Inhibition: Clinical Implications for Cancer

  2003cites this paper
• Alternative approaches to the discovery and development of telomerase-targeted anticancer drugs.

  2003cites this paper
• Telomerases, telomeres, and cancer

  2002influential citation
• Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation

  2001cites this paper
• Complex regulation of telomerase activity: implications for cancer therapy.

  2001cites this paper
• Anti-Aging Medicine LiteratureWatch

  2001cites this paper
• Commentary Complex Regulation of Telomerase Activity Implications for Cancer Therapy

  year unknowncites this paper